New Data From CombiMatrix Study Support Follow-Up Diagnostic Testing to Confirm Positive Results From Non-Invasive Prenatal Testing
09 oct. 2015 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 9, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at Upcoming Investment Conferences
22 sept. 2015 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 22, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at Rodman & Renshaw Global Investment Conference
02 sept. 2015 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix's CombiSNP Array for Prenatal Diagnosis Test Granted Approval From New York State Department of Health
18 août 2015 07h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Corporation Reports Second Quarter 2015 Financial and Operating Results
05 août 2015 16h05 HE
|
CombiMatrix Corporation
Marks 7th Consecutive Quarter of Record Prenatal Microarray Test Revenues and Volumes
Conference Call Begins Today at 4:30 p.m. Eastern Time
IRVINE, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) --...
CombiMatrix Corporation to Hold 2015 Second Quarter Conference Call on August 5
29 juil. 2015 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., July 29, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the quarter ended June 30, 2015 after market close on...